Locations:
Search IconSearch
June 3, 2019/Cancer

Intraoperative Enteroscopy in Peutz–Jeghers Syndrome

Case Report and Images of Note

By Carole Burke, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Background

Peutz-Jeghers Syndrome (PJS) is a hereditary cancer syndrome characterized by benign hamartomatous, primarily gastrointestinal (GI), polyps; muco-cutaneous pigmentation; and a high predisposition to many intestinal and extra-intestinal cancers.

PJS is caused by a mutation of the STK11/LKB1 gene, which normally functions as a tumor suppressor and cell growth regulator. Mutation disrupts the gene’s ability to curtail cell division, leading to polyps and cancer.

Approximately half of cases are inherited from a parent; the remainder occur in patients with no family history of PJS and appear to result from a spontaneous mutation. A patient with PJS has a 50% chance of passing the condition on to their offspring. PJS is relatively rare, affecting one in 25,000 to 300,000 live births of all ethnicities.

Polyps typically occur beginning in childhood in the small intestine but also manifest throughout the intestinal tract and outside the intestinal tract in the renal pelvis, lungs, gall bladder, nasal passages, urinary bladder and ureters. Hyperpigmentation — dark blue or brown macules — on the border of the lips and inside the mouth are a tip-off to the diagnosis of PJS and appear in childhood. The pigment may lessen in adolescence and adulthood, and can also occur near the eyes and nostrils, in the perianal area and sometimes on the hands and feet.

PJS patients have a 90% lifetime risk of cancer, including colorectal (most common — lifetime risk 39 percent), gastric, pancreatic, lung, breast, uterine, cervical, testicular and ovarian.

Advertisement

Small bowel obstruction resulting from polyps is a common complication, often in childhood, requiring surgical intervention. Regular imaging studies (MRI/MRE or CT/CTE) and endoscopic surveillance and polypectomy of the intestinal tract, beginning in early adolescence, can reduce the likelihood of intestinal complications. Many other organs in PJS patients require special surveillance for potential malignancies.

Case Report

A 39-year-old Asian female presented to Cleveland Clinic’s Digestive Disease & Surgery Institute for evaluation of recurrent small bowel obstruction (SBO) in the preceding year. She recently had been diagnosed with PJS, with genetic testing showing deletion of exons 2–8 in the STK11 gene.

She had undergone abdominal surgery of unknown type at age 2 years.

Endoscopic evaluation during the previous six months revealed multiple hamartomatous polyps, 0.5–4 cm in size, throughout the stomach, small bowel and colon. Computerized tomographic enterography revealed multiple dilated small bowel loops with scattered foci of intussusception, suspected to be due to hamartomatous polyps, leading to recurrent SBO.

Exploratory laparotomy with surgically assisted enteroscopy to the terminal ileum and removal of clinically significant polyps, i.e., “clean sweep,” was planned.

Intraoperative findings included extensive intra-abdominal adhesions and prior small bowel resection, with an anastomotic stricture 60 cm proximal to the ileocecal valve. Surgical adhesiolysis and small bowel resection was performed, along with endoscopic removal of more than 30 polyps >10 cm in size and more than 35 polyps 2–10 cm in size.

Advertisement

These unique intraoperative endoscopic images, obtained with the patient’s consent and originally published in the American Journal of Gastroenterology, depict:

Figure 1a — The transilluminated jejunum and ileum.

Figure 1b — Large polyps in the jejunum and ileum.

Figure 1c — Resection of polyps using hot snares and retrieval with a Roth Net or by enterotomy.

Outcome

The patient has done well after surgery and returns for routine procedures recommended for patients with PJS.

We are fortunate that innovations in small bowel imaging such as video capsule endoscopy and MRI enterography are available to screen for small bowel polyps, and that advances in endoscopic equipment such as balloon enteroscopy are available to remove polyps deep in the small intestine, avoiding the need for emergency surgery in PJS patients.

Dr. Burke is Vice Chair of Cleveland Clinic’s Department of Gastroenterology and Hepatology and Section Head of Polyposis in the Sanford R. Weiss, MD, Center for Hereditary Colorectal Neoplasia.

Adapted from Rao BB, Kalady MF, Burke CA. Intraoperative Enteroscopy in Peutz-Jeghers Syndrome. Am J Gastroenterol. 2018 Jun;113(6):799.

Intraoperative images © The American College of Gastroenterology 2018. Used with permission.

Advertisement

Related Articles

Immune checkpoint inhibitor illustration
June 12, 2026/Cancer/News & Insight

Immunotherapy Appears to Reduce the Risk of Secondary Primary Cancers

Large-scale database also reveals potential for immunotherapy to protect against cancer

T53 mutation illustration
June 10, 2026/Cancer/News & Insight

TP53 Mutation Acquisition Timing Influences Prognosis in Myeloproliferative Neoplasms

Findings may help guide discussions around prognosis and allogeneic stem cell transplantation

Woman consoling another
June 5, 2026/Cancer/Blood Cancers

Equal Access to Modern Therapy May Help Eliminate Survival Differences in Multiple Myeloma

Research underscores the importance of access to timely diagnosis and treatment in this patient population.

Multiple myeloma cells
June 4, 2026/Cancer/Blood Cancers

Machine Learning Model Outperforms Standard Risk Tools for Multiple Myeloma

A Cleveland Clinic model combining clinical staging, genomics and AI predicts survival with 18% greater accuracy — and could help match patients to more effective treatments.

Dr. Kamath & colleagues in the lab
June 2, 2026/Cancer/News & Insight

Tissue Tumor Mutation Burden Outperforms Blood-Based Testing for Predicting Immunotherapy Response

Study serves as ‘cautionary tale’ for physicians tempted to rely on liquid biopsy results alone

Patient with nebulizer
June 1, 2026/Cancer/Innovations

Adding Novel Inhaled Agent May Improve Lung Cancer Outcomes

Direct delivery of viral-based vector KB707 to the lungs may boost anti-tumor response and help overcome immune checkpoint inhibitor resistance

Acupuncture in wrist
May 29, 2026/Cancer/Patient Support

Can Acupuncture Really Help with Cancer Treatment Side Effects?

Evidence-based recommendations for managing pain, nausea and other treatment reactions

Head and neck cancer illustration
May 28, 2026/Cancer

What Is the Outlook for Treatment De-Intensification Strategies for Head & Neck Cancer?

Emerging data and practice changes reduce toxicity burden of treatment

Ad